Bulletin
Investor Alert

New York Markets Open in:

Market Snapshot Analyst Ratings

Vir Biotechnology Inc.

NAS: VIR

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Vir Biotechnology Inc.

After Hours

 --Quotes are delayed by 20 min

Apr 20, 2021, 7:57 p.m.

VIR
/zigman2/quotes/214486077/composite

$

48.99

Change

+0.54 +1.09%

Volume

Volume 300,279

Quotes are delayed by 20 min

/zigman2/quotes/214486077/composite

Previous close

$ 47.22

$ 48.46

Change

+1.24 +2.63%

Day low

Day high

$46.61

$49.19

Open

52 week low

52 week high

$25.31

$141.01

Open
Income Statement Balance Sheet Cash Flow Statement

Annual Financials for Vir Biotechnology Inc.

View Ratios
Fiscal year is January-December. All values USD millions. 2017201820192020 5-year trend
Sales/Revenue -2.71M10.67M8.09M76.37M
Cost of Goods Sold (COGS) incl. D&A -----
COGS excluding D&A -----
Depreciation & Amortization Expense -432,0002.76M4.52M8.81M
Depreciation -255,0001.62M3.29M7.77M
Amortization of Intangibles -177,0001.14M1.22M1.04M
Gross Income -----
2017201820192020 5-year trend
SG&A Expense -83.07M126.6M177.07M363.7M
Research & Development -62.08M97.47M139.48M296.14M
Other SG&A -20.99M29.13M37.6M67.57M
Other Operating Expense -----
Unusual Expense -700,000-9.23M832,000
EBIT after Unusual Expense -(81.5M)-(182.73M)(296.98M)
Non Operating Income/Expense -83,000(212,000)(312,000)(4.47M)
Non-Operating Interest Income -638,0002.54M8.51M2.84M
Equity in Affiliates (Pretax) -----
Interest Expense -----
Gross Interest Expense -----
Interest Capitalized -----
Pretax Income -(80.78M)(116.36M)(174.53M)(298.61M)
Income Tax -(10.92M)(480,000)154,00054,000
Income Tax - Current Domestic -----
Income Tax - Current Foreign --20,000154,000106,000
Income Tax - Deferred Domestic -(10.92M)(500,000)-(52,000)
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income -(69.85M)(115.88M)(174.68M)(298.67M)
Minority Interest Expense -----
Net Income -(69.85M)(115.88M)(174.68M)(298.67M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries -(69.85M)(115.88M)(174.68M)(298.67M)
Preferred Dividends -----
Net Income Available to Common -(69.85M)(115.88M)(174.68M)(298.67M)
EPS (Basic) -(0.64)(1.06)(1.62)(2.51)
Basic Shares Outstanding -109.68M109.68M107.65M119.16M
EPS (Diluted) -(0.64)(1.06)(1.62)(2.51)
Diluted Shares Outstanding -109.68M109.68M107.65M119.16M
EBITDA -(80.37M)(115.94M)(168.98M)(287.34M)
Copyright 2021 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Link to MarketWatch's Slice.